Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new publication citation related to NODE-303 was added to the Publications section, describing a post hoc analysis of self-administered etripamil nasal spray in atrial fibrillation.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.2%

- Check25 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check32 days agoChange DetectedUI and metadata updates include adding a Show glossary option, adding Last Update Submitted that Met QC Criteria, standardizing 'No FEAR Act Data' capitalization, and updating the revision label to v3.4.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study content or page data.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a comprehensive locations section (including US states and international sites such as Buenos Aires, REG1, British Columbia, Ontario, and Quebec) and updated the revision to v3.3.3, while removing the previous v3.3.2 location blocks.SummaryDifference2%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.